Magliano DJ, Boyko EJ, committee IDFDAtes (2021) IDF Diabetes Atlas. In: Idf diabetes atlas. International Diabetes Federation © International Diabetes Federation, Brussels

Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z, Zhang X, Li C, Huang Z, Sun X et al (2021) Prevalence and treatment of diabetes in China, 2013–2018. JAMA 326:2498–2506. https://doi.org/10.1001/jama.2021.22208

Article  PubMed  PubMed Central  Google Scholar 

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE et al (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139:e1046–e1081. https://doi.org/10.1161/cir.0000000000000624

Article  PubMed  Google Scholar 

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA et al (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41:111–188. https://doi.org/10.1093/eurheartj/ehz455

Article  PubMed  Google Scholar 

Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK (2010) Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol 55:1209–1216. https://doi.org/10.1016/j.jacc.2009.10.053

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erlandson KM, Jiang Y, Debanne SM, McComsey GA (2015) Rosuvastatin worsens insulin resistance in HIV-infected adults on antiretroviral therapy. Clin Infect Dis: Off Publ Infect Dis Soc Am 61:1566–1572. https://doi.org/10.1093/cid/civ554

Article  CAS  Google Scholar 

Cederberg H, Stančáková A, Yaluri N, Modi S, Kuusisto J, Laakso M (2015) Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort. Diabetologia 58:1109–1117. https://doi.org/10.1007/s00125-015-3528-5

Article  CAS  PubMed  Google Scholar 

Mansi IA, Chansard M, Lingvay I, Zhang S, Halm EA, Alvarez CA (2021) Association of statin therapy initiation with diabetes progression: a retrospective matched-cohort study. JAMA Intern Med 181:1562–1574. https://doi.org/10.1001/jamainternmed.2021.5714

Article  CAS  PubMed  Google Scholar 

Erqou S, Lee CC, Adler AI (2014) Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis. Diabetologia 57:2444–2452. https://doi.org/10.1007/s00125-014-3374-x

Article  CAS  PubMed  Google Scholar 

Bardini G, Giannini S, Rotella CM, Pala L, Cresci B, Mannucci E (2016) Lower and higher-potency statins on glycemic control in type 2 diabetes: a retrospective cohort study. Diabetes Res Clin Pract 120:104–110. https://doi.org/10.1016/j.diabres.2016.07.015

Article  CAS  PubMed  Google Scholar 

Li H, Zuo Y, Qian F, Chen S, Tian X, Wang P, Li X, Guo X, Wu S, Wang A (2022) Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol 21:105. https://doi.org/10.1186/s12933-022-01541-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui H, Liu Q, Wu Y, Cao L (2022) Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol 21:22. https://doi.org/10.1186/s12933-022-01456-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou YF, Wang Y, Wang G, Zhou Z, Chen S, Geng T, Zhang YB, Wang Y, Chen JX, Pan A et al (2022) Association between statin use and progression of arterial stiffness among adults with high atherosclerotic risk. JAMA Netw Open 5:e2218323. https://doi.org/10.1001/jamanetworkopen.2022.18323

Article  PubMed  PubMed Central  Google Scholar 

Shipman KE, Jawad M, Sullivan KM, Ford C, Gama R (2014) HbA1c is a reliable test for type 2 diabetes in primary care irrespective of chronic kidney disease. BMJ (Clinical research ed) 348:g3780. https://doi.org/10.1136/bmj.g3780

Article  CAS  PubMed  Google Scholar 

Yoshida K, Solomon DH, Kim SC (2015) Active-comparator design and new-user design in observational studies. Nat Rev Rheumatol 11:437–441. https://doi.org/10.1038/nrrheum.2015.30

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lund JL, Richardson DB, Stürmer T (2015) The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep 2:221–228. https://doi.org/10.1007/s40471-015-0053-5

Article  PubMed  PubMed Central  Google Scholar 

Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet (London, England) 369:107–114. https://doi.org/10.1016/s0140-6736(07)60071-3

Article  CAS  PubMed  Google Scholar 

Jin C, Chen S, Vaidya A, Wu Y, Wu Z, Hu FB, Kris-Etherton P, Wu S, Gao X (2017) Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes. Diabetes Care 40:1565–1572. https://doi.org/10.2337/dc17-0610

Article  CAS  PubMed  PubMed Central  Google Scholar 

(2022) 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care 45:S17–s38. https://doi.org/10.2337/dc22-S002

Li Y, Huang Z, Jin C, Xing A, Liu Y, Huangfu C, Lichtenstein AH, Tucker KL, Wu S, Gao X (2018) Longitudinal change of perceived salt intake and stroke risk in a Chinese population. Stroke 49:1332–1339. https://doi.org/10.1161/strokeaha.117.020277

Article  PubMed  PubMed Central  Google Scholar 

Wu S, Huang Z, Yang X, Zhou Y, Wang A, Chen L, Zhao H, Ruan C, Wu Y, Xin A et al (2012) Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes 5:487–493. https://doi.org/10.1161/circoutcomes.111.963694

Article  PubMed  Google Scholar 

Wu Z, Huang Z, Jin W, Rimm EB, Lichtenstein AH, Kris-Etherton PM, Wu S, Gao X (2017) Peripheral inflammatory biomarkers for myocardial infarction risk: a prospective community-based study. Clin Chem 63:663–672. https://doi.org/10.1373/clinchem.2016.260828

Article  CAS  PubMed  Google Scholar 

Bartlett JW, Seaman SR, White IR, Carpenter JR (2015) Multiple imputation of covariates by fully conditional specification: accommodating the substantive model. Stat Methods Med Res 24:462–487. https://doi.org/10.1177/0962280214521348

Article  PubMed  PubMed Central  Google Scholar 

Liu H, Chen S, Li Z, Xing A, Liu Y, Yu J, Li D, Li Y, Zhou X, Yang Q et al (2022) Long-term risks for cardiovascular disease and mortality across the glycaemic spectrum in a male-predominant Chinese cohort aged 75 years or older: the Kailuan study. Age Ageing 51. https://doi.org/10.1093/ageing/afac109

Niiranen TJ, Kalesan B, Mitchell GF, Vasan RS (2019) Relative contributions of pulse pressure and arterial stiffness to cardiovascular disease. Hypertension (Dallas, Tex : 1979) 73:712–717. https://doi.org/10.1161/hypertensionaha.118.12289

Article  CAS  PubMed  Google Scholar 

Ganatra RB, Bhatnagar A, Herzig SJ (2022) Strengthening a study of diabetes progression after statin use. JAMA Intern Med 182:459–460. https://doi.org/10.1001/jamainternmed.2021.8353

Article  PubMed  Google Scholar 

Liew SM, Lee PY, Hanafi NS, Ng CJ, Wong SS, Chia YC, Lai PS, Zaidi NF, Khoo EM (2014) Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes. Diabetol Metab Syndr 6:53. https://doi.org/10.1186/1758-5996-6-53

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sukhija R, Prayaga S, Marashdeh M, Bursac Z, Kakar P, Bansal D, Sachdeva R, Kesan SH, Mehta JL (2009) Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Invest Med: Off Publ Am Fed Clin Res 57:495–499. https://doi.org/10.2310/JIM.0b013e318197ec8b

Article  CAS  Google Scholar 

Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA et al (2015) HMG-coenzyme A reductase inhibition,